Suche

Programmdetails

Postervorträge

HFpEF – mechanisms

Freitag, 25. April | 09:45 - 10:45 Uhr | Posterbereich 25

Vorsitz/Chair: Jes-Niels Boeckel (Leipzig), Badder Kattih (Frankfurt am Main)

Agenda

(P999)
A novel approach for mouse echocardiography expanding accessibility and enabling retrospective analysis in diastolic function assessment
M. Marterstock (Dresden)
(P1000)
TSC2 serine 1365 phosphorylation improves liver metabolism to rescue murine heart failure with preserved ejection fraction
S. Fu (Berlin)
(P1001)
Myocardial substrate metabolism and regional ventricular wall deformation are altered in a diabetes associated HFpEF mouse model
A. Heinen (Düsseldorf)
(P1002)
Inflammatory and metabolic activation of immune cells as a hallmark of HFpEF: New insights and therapeutic perspectives
J. M. Kneuer (Leipzig)
(P1003)
Combined effects of semaglutide and empagliflozin on cardiomyocyte function and mitochondrial respiration in a rat model of HFpEF: a sex-specific analysis
N. Geiger (Würzburg)
(P1004)
A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy
K. Kohlat (Berlin)
(P1005)
Neuregulin 1 regulates pericyte function in heart failure with preserved ejection fraction in a sex-specific manner
L. R. Vanicek (Frankfurt am Main)
(P1006)
Distinct sex-specific effects of semaglutide on cardiomyocyte function and mitochondrial respiration in a rat model of HFpEF
P. Zytner (Würzburg)
Diese Seite teilen